{4 (0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector [Idacio]) } Pack [Idacio Pen 40 MG/0.8 ML Starter Pack - Plaque Psoriasis]

RxCUI: 2640865
RxNorm name: {4 (0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector [Idacio]) } Pack [Idacio Pen 40 MG/0.8 ML Starter Pack - Plaque Psoriasis]
Display name: {4 (0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector [Idacio]) } Pack [Idacio Pen 40 MG/0.8 ML Starter Pack - Plaque Psoriasis]
Full name: {4 (0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector [Idacio]) } Pack [Idacio Pen 40 MG/0.8 ML Starter Pack - Plaque Psoriasis]
Term type: BPCK
Status: DailyMed mapping
Updated: 2026-06-04 23:38:56

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLA	Proprietary name	Proper name	License type	Status	Latest source
761255	Idacio	adalimumab-aacf	351(k) Biosimilar	Rx	2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Idacio	ADALIMUMAB-AACF	Fresenius Kabi USA, LLC	43de75ac-1a37-4609-9edd-68bda2448a47	2026-01-30	Boxed warning, Warnings, Adverse reactions	Exact identifier rxcui: 2640865

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
43de75ac-1a37-4609-9edd-68bda2448a47	{4 (0.8 ML adalimumab-aacf 50 MG/ML Auto-Injector [Idacio]) } Pack [Idacio Pen 40 MG/0.8 ML Starter Pack - Plaque Psoriasis] [BPCK] · Idacio Pen 40 MG/0.8 ML Starter Pack - Plaque Psoriasis (4 count) [PSN] · Idacio Pen 40 MG/0.8 ML Starter Pack - Plaque Psoriasis (4 count) [SY]	3	7	These highlights do not include all the information needed to use IDACIO safely and effectively. See full prescribing information for IDACIO. IDACIO® (adalimumab-aacf) injection, for subcutaneous use Initial U.S. Approval: 2022 IDACIO® (adalimumab-aacf) is biosimilar Biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product, known as a reference product, and that there are no clinically meaningful differences between	20260130